Health care companies by P/S ratio
Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.
Centene has the lowest figure of the 154 health care companies ranked by P/S ratio, at 0.2, followed by Cencora (0.2) and Molina Healthcare (0.2). Figures as of 19 Nov 2026, 16:02 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 154
- Lowest
- Centene0.2
- Median
- 4.2
- Combined market value
- TRY 450.8T
- Countries
- 14
- Not ranked
- 16no P/S ratio on file
Market values as of .
All countries▾
Health Care▾
All categories▾
| # | Company | P/S ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 101 | Gilead SciencesGILD · Health Care | 7.0 | TRY 10.38T | TRY 8,365.24 | 1.90% down | 35% up | ||
| 102 | Medpace HoldingsMEDP · Health Care | 7.1 | TRY 902.8B | TRY 32,275.57 | 1.13% down | 10% up | ||
| 103 | Agilent TechnologiesA · Health Care | 7.2 | TRY 2.54T | TRY 9,000.56 | 0.58% up | 22% up | ||
| 104 | IlluminaILMN · Health Care | 7.4 | TRY 1.61T | TRY 10,658.78 | 0.58% up | 76% up | ||
| 105 | Arrowhead PharmaceuticalsARWR · Health Care | 7.4 | TRY 310.5B | TRY 2,196.65 | 0.97% up | 13% up | ||
| 106 | United TherapeuticsUTHR · Health Care | 7.5 | TRY 1.2T | TRY 28,182.78 | 3.27% down | 22% up | ||
| 107 | Halozyme TherapeuticsHALO · Health Care | 7.5 | TRY 527.9B | TRY 4,630.22 | 4.22% down | 39% up | ||
| 108 | AbbVieABBV · Health Care | 8.1 | TRY 25.04T | TRY 14,166.96 | 1.84% down | 25% up | ||
| 109 | Mettler-Toledo InternationalMTD · Health Care | 8.5 | TRY 1.72T | TRY 86,681.15 | 1.12% down | 24% up | ||
| 110 | GenmabGMAB · Health Care | 8.5 | TRY 1.6T | TRY 2,599.60 | 1.07% up | 70% up | ||
| 111 | BeOne MedicinesONC · Health Care | 8.6 | TRY 2.31T | TRY 20,214.94 | 0.75% down | 16% up | ||
| 112 | PenumbraPEN · Health Care | 9.0 | TRY 636.4B | TRY 16,146.62 | 0.20% down | 15% up | ||
| 113 | West Pharmaceutical ServicesWST · Health Care | 9.0 | TRY 1.4T | TRY 20,151.86 | 1.16% down | 57% up | ||
| 114 | Corcept TherapeuticsCORT · Health Care | 9.4 | TRY 361B | TRY 3,298.26 | 3.58% down | 10% down | ||
| 115 | Bio-TechneTECH · Health Care | 9.4 | TRY 576.4B | TRY 3,669.41 | 0.05% down | 24% up | ||
| 116 | Madrigal PharmaceuticalsMDGL · Health Care | 9.7 | TRY 467B | TRY 20,103.16 | 0.07% up | 27% down | ||
| 117 | Travere TherapeuticsTVTX · Health Care | 9.7 | TRY 240.6B | TRY 2,506.49 | 1.13% down | 45% up | ||
| 118 | Edwards LifesciencesEW · Health Care | 9.9 | TRY 3.03T | TRY 5,265.41 | 0.84% down | 25% up | ||
| 119 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | 11.0 | TRY 375.2B | TRY 4,774.80 | 0.45% down | 129% up | ||
| 120 | Axsome TherapeuticsAXSM · Health Care | 11.0 | TRY 355B | TRY 6,748.40 | 0.20% down | 6% down | ||
| 121 | Vertex PharmaceuticalsVRTX · Health Care | 11.1 | TRY 6.7T | TRY 26,433.48 | 2.35% down | 27% up | ||
| 122 | Mirum PharmaceuticalsMIRM · Health Care | 11.8 | TRY 310.3B | TRY 4,753.86 | 1.85% up | 34% up | ||
| 123 | 10x GenomicsTXG · Health Care | 12.3 | TRY 400.2B | TRY 3,042.41 | 5.64% up | 247% up | ||
| 124 | IDEXX LaboratoriesIDXX · Health Care | 12.6 | TRY 2.74T | TRY 34,839.85 | 1.15% down | 1% up | ||
| 125 | argenxARGX · Health Care | 14.2 | TRY 2.98T | TRY 47,348.34 | 0.32% down | 2% up | ||
| 126 | Intuitive SurgicalISRG · Health Care | 14.3 | TRY 7.27T | TRY 20,961.28 | 1.32% down | 24% down | ||
| 127 | BillionToOneBLLN · Health Care | 14.3 | TRY 220.3B | TRY 4,611.55 | 0.17% down | 4% down | ||
| 128 | RepligenRGEN · Health Care | 15.1 | TRY 564.3B | TRY 8,828.49 | 1.32% up | 12% up | ||
| 129 | TG TherapeuticsTGTX · Health Care | 16.2 | TRY 504.7B | TRY 3,339.13 | 0.08% up | 117% up | ||
| 130 | Royalty PharmaRPRX · Health Care | 16.4 | TRY 1.97T | TRY 3,429.21 | 1.04% down | 79% up | ||
| 131 | Adaptive BiotechnologiesADPT · Health Care | 16.9 | TRY 236.6B | TRY 1,461.91 | 1.79% up | 74% up | ||
| 132 | Eli LillyLLY · Health Care | 18.4 | TRY 60.68T | TRY 68,117.36 | 2.38% down | 33% up | ||
| 133 | NateraNTRA · Health Care | 18.8 | TRY 2.19T | TRY 15,075.29 | 3.19% up | 28% up | ||
| 134 | Guardant HealthGH · Health Care | 20.9 | TRY 1.03T | TRY 7,639.33 | 4.30% up | 45% up | ||
| 135 | Ligand PharmaceuticalsLGND · Health Care | 21.7 | TRY 293.4B | TRY 14,666.54 | 2.70% down | 50% up | ||
| 136 | Ascendis PharmaASND · Health Care | 21.8 | TRY 877.7B | TRY 13,380.24 | 1.92% down | 29% up | ||
| 137 | Twist BioscienceTWST · Health Care | 21.9 | TRY 416.7B | TRY 6,112.57 | 4.11% up | 346% up | ||
| 138 | HeartflowHTFL · Health Care | 22.5 | TRY 200.1B | TRY 2,277.14 | 1.67% down | 66% up | ||
| 139 | Krystal BiotechKRYS · Health Care | 23.8 | TRY 466.6B | TRY 15,745.44 | 1.05% down | 54% up | ||
| 140 | GlaukosGKOS · Health Care | 27.3 | TRY 699.3B | TRY 11,813.62 | 0.44% up | 145% up | ||
| 141 | WatersWAT · Health Care | 28.8 | TRY 4.6T | TRY 23,411.26 | 0.47% down | 23% up | ||
| 142 | BridgeBio PharmaBBIO · Health Care | 30.4 | TRY 770.9B | TRY 3,957.55 | 0.53% up | 21% up | ||
| 143 | GRAILGRAL · Health Care | 33.0 | TRY 245.2B | TRY 5,453.53 | 5.85% up | 19% up | ||
| 144 | ModernaMRNA · Health Care | 41.0 | TRY 4.02T | TRY 9,937.66 | 0.07% up | 780% up | ||
| 145 | Rhythm PharmaceuticalsRYTM · Health Care | 42.7 | TRY 408.4B | TRY 5,891.04 | 1.93% down | 18% up | ||
| 146 | InsmedINSM · Health Care | 50.7 | TRY 1.55T | TRY 7,071.37 | 16.97% up | 40% down | ||
| 147 | ImmunityBioIBRX · Health Care | 61.1 | TRY 349.2B | TRY 328.26 | 2.91% down | 232% up | ||
| 148 | CytokineticsCYTK · Health Care | 80.5 | TRY 357.8B | TRY 2,568.44 | 0.82% down | 19% down | ||
| 149 | Protagonist TherapeuticsPTGX · Health Care | 180 | TRY 417.2B | TRY 6,391.63 | 0.39% down | 51% up | ||
| 150 | Kymera TherapeuticsKYMR · Health Care | 259 | TRY 511.8B | TRY 5,994.99 | 1.92% down | 87% up | ||
| 151 | CRISPR TherapeuticsCRSP · Health Care | 1121 | TRY 198.6B | TRY 2,047.78 | 0.97% up | 18% down | ||
| 152 | CG OncologyCGON · Health Care | 1812 | TRY 369.5B | TRY 4,136.44 | 2.46% up | 97% up | ||
| 153 | Dianthus TherapeuticsDNTH · Health Care | 2346 | TRY 241B | TRY 4,280.52 | 1.01% up | 108% up | ||
| 154 | Roivant SciencesROIV · Health Care | 3446 | TRY 1.44T | TRY 1,982.69 | 1.45% up | 91% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. P/S divides today's market value by the latest fiscal year's revenue from the annual report. Sums are converted from US dollars at today's exchange rate (1 USD = 50.4629 TRY). 16 companies have no P/S ratio on file and are not ranked here.
Questions and answers
Which health care companies have the lowest P/S ratio?
Centene (0.2), Cencora (0.2) and Molina Healthcare (0.2) have the lowest P/S ratio of the 154 health care companies ranked here as of 19 Nov 2026, 16:02 UTC.
How many health care companies are in this ranking?
154 are ranked by P/S ratio. 16 more have no P/S ratio on file and are left out rather than ranked at zero.
What are these health care companies worth together?
The 154 health care companies ranked by P/S ratio have a combined market value of TRY 450.8T as of 19 Nov 2026, 16:02 UTC.
What does ranking by P/S ratio measure?
Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.
Learn how this ranking works
All markets guides →- P/E ratio explained: what a high or low figure means
The price-to-earnings (P/E) ratio is a share's price divided by its earnings per share. A stock at $100 earning $5 a share has a P/E of 20: buyers pay $20 for each dollar of yearly profit. A high P/E usually means the market expects profit to grow; a low one can mean doubt, not a bargain.
- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Health care companies by P/S ratio”, data as of 19 November 2026. https://funkfolio.com/companies/sector/health-care?by=ps-ratio
Underlying data: Yahoo Finance; SEC EDGAR.